Biohaven Pharmaceutical Holding Company Ltd. is a US-based biopharmaceutical firm that specializes in drugs for neurological and neuropsychiatric disorders, along with rare conditions. Among its products are NURTEC ODT (rimegepant) for treating migraines, BHV-3100 for non-migraine indications, and Troriluzole for Alzheimer's, obsessive-compulsive disorders, and spinocerebellar ataxia. Cove is partnering with the organization to offer telemedicine evaluations for individuals experiencing migraines.